MAINTENANCE OF REMISSION WITH TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS: FINAL RESULTS OF A SUBPOPULATION ANALYSIS FROM AN OPEN-LABEL, LONG-TERM EXTENSION STUDY, OCTAVE OPEN

Jean-Frédéric Colombel  1     Mark T. Osterman  2     Patricio Ibáñez  3     Severine Vermeire  4     Peter Irving  5     Sean Gardiner  6     Susan B. Connelly  7     Rajiv Mundayat  7     Nervin Lawendy  7     Chinyu Su  7     Walter Reinisch  8    
1 Department of Gastroenterology, New York, NY, United States
2 University of Pennsylvania, Philadelphia, PA, United States
3 Gastroenterology Department, Santiago, Chile
4 Department of Gastroenterology, Leuven, Belgium
5 IBD Unit, London, United Kingdom
6 Pfizer Inc, New York, NY, United States
7 Pfizer Inc, Collegeville, PA, United States
8 Department of Internal Medicine III, Vienna, Austria

Topic
IBD

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing